Key result
First-degree atrioventricular block was independently associated with a increased risk of HCM-related death in patients with hypertrophic cardiomyopathy.
Why the study?
First-degree atrioventricular block on 12-lead ECG is increasingly recognized for its impact on cardiovascular events, but whether it confers cardiovascular risk in patients with hypertrophic cardiomyopathy was unclear.
Does first-degree atrioventricular block predict HCM-related death in patients with hypertrophic cardiomyopathy?
Cohort (n=414)
No
Does first-degree atrioventricular block predict HCM-related death in patients with hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
First-degree atrioventricular block is a simple and useful electrocardiographic marker that independently predicts HCM-related death, including sudden cardiac death, in patients with hypertrophic cardiomyopathy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Higuchi et al. (2021) conducted a cohort in Hypertrophic Cardiomyopathy (n=414). First-degree atrioventricular block vs. No first-degree atrioventricular block was evaluated on HCM-related death (composite of sudden death, potentially lethal arrhythmic events, heart failure-related death, and stroke-related death) (HR 2.41, 95% CI 1.27-4.58, p=0.007). First-degree atrioventricular block was independently associated with a increased risk of HCM-related death in patients with hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: